retatrutide clinical trials results NEW Phase 3 Trial Review retatrutide clinical trial results safety

And understanding the risks in adolescents, whose use of GLP-1 drugs has soared since they were approved for the age group in the US in 2020, is particularly important, doctors say

2017 Sep 21 [cited 2018 Oct 17];377(12):114355

Ozempic While approved initially for the treatment of type 2 diabetes, Ozempic is also a powerful tool for weight loss

GLP-1 receptor agonists are a class of medications that mimic the action of glucagon-like peptide-1, a naturally occurring hormone in the body

The GIP receptor activation brings its own party tricks to the table, improving insulin sensitivity and potentially enhancing fat metabolism in ways that GLP-1 alone cannot achieve

Frequently Asked Questions Provider-Guided Weight-Loss Care Get provider-guided treatment, practical support, and tools to help you navigate appetite changes, meals, and progress along the way.